77 related articles for article (PubMed ID: 9110095)
1. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis.
Di Stefano M; Monno L; Fiore JR; Angarano G
AIDS; 1997 Jan; 11(1):133-5. PubMed ID: 9110095
[No Abstract] [Full Text] [Related]
2. [Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
Bossi P; Dupré S; Dupin N; Coutellier A; Bricaire F; Lubetzki C; Katlama C; Calvez V
Pathol Biol (Paris); 1998 Jun; 46(6):423-5. PubMed ID: 9769875
[TBL] [Abstract][Full Text] [Related]
3. Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid.
Tambussi G; Gori A; Capiluppi B; Balotta C; Papagno L; Morandini B; Di Pietro M; Ciuffreda D; Saracco A; Lazzarin A
Clin Infect Dis; 2000 Jun; 30(6):962-5. PubMed ID: 10880317
[TBL] [Abstract][Full Text] [Related]
4. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?
Price RW; Staprans S
Ann Neurol; 1997 Nov; 42(5):675-8. PubMed ID: 9392565
[No Abstract] [Full Text] [Related]
5. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART].
Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M
Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421
[TBL] [Abstract][Full Text] [Related]
6. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection.
Enting RH; Prins JM; Jurriaans S; Brinkman K; Portegies P; Lange JM
Clin Infect Dis; 2001 Apr; 32(7):1095-9. PubMed ID: 11264039
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations of discordance between cerebrospinal fluid and plasma HIV-1 loads.
Jenny-Avital ER; Chuang C
Clin Infect Dis; 2002 Dec; 35(12):1576-7. PubMed ID: 12471586
[No Abstract] [Full Text] [Related]
8. Interpretation of high levels of HIV-1 RNA in the cerebrospinal fluid (CSF) using amplicor HIV-1 monitor test.
Honderlick P; Zucman D; Couderc LJ
Pathol Biol (Paris); 1999 May; 47(5):560-2. PubMed ID: 10418040
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.
Ellis RJ; Childers ME; Zimmerman JD; Frost SD; Deutsch R; McCutchan JA;
J Infect Dis; 2003 Jun; 187(11):1818-21. PubMed ID: 12751041
[TBL] [Abstract][Full Text] [Related]
10. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.
Günthard HF; Havlir DV; Fiscus S; Zhang ZQ; Eron J; Mellors J; Gulick R; Frost SD; Brown AJ; Schleif W; Valentine F; Jonas L; Meibohm A; Ignacio CC; Isaacs R; Gamagami R; Emini E; Haase A; Richman DD; Wong JK
J Infect Dis; 2001 May; 183(9):1318-27. PubMed ID: 11294662
[TBL] [Abstract][Full Text] [Related]
11. Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy.
Stellbrink HJ; Eggers C; van Lunzen J; Albrecht H; Greten H
AIDS; 1997 Nov; 11(13):1655-7. PubMed ID: 9365775
[No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy.
Yilmaz A; Svennerholm B; Hagberg L; Gisslén M
Antivir Ther; 2006; 11(7):833-7. PubMed ID: 17302245
[TBL] [Abstract][Full Text] [Related]
13. Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient.
Delaugerre C; Denis B; Peytavin G; Palmer P; Mourez T; Le Goff J; Molina JM; Simon F
J Clin Microbiol; 2009 Nov; 47(11):3763-4. PubMed ID: 19759232
[TBL] [Abstract][Full Text] [Related]
14. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals.
von Geldern G; Cepok S; Nolting T; Du Y; Grummel V; Adams O; Hartung HP; Arendt G; Hemmer B
AIDS; 2007 Jan; 21(2):250-3. PubMed ID: 17197822
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment.
Mellgren A; Antinori A; Cinque P; Price RW; Eggers C; Hagberg L; Gisslén M
Antivir Ther; 2005; 10(6):701-7. PubMed ID: 16218168
[TBL] [Abstract][Full Text] [Related]
16. Does the human immunodeficiency virus (HIV) RNA concentration in cerebrospinal fluid help clinicians diagnose or understand HIV-induced neurological disease?
Daar ES
Clin Infect Dis; 1998 May; 26(5):1074-5. PubMed ID: 9597228
[No Abstract] [Full Text] [Related]
17. The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART.
Belmonte L; Olmos M; Fanin A; Parodi C; Baré P; Concetti H; Pérez H; de Bracco MM; Cahn P
AIDS; 2007 Oct; 21(15):2106-8. PubMed ID: 17885303
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy.
Iftimovici E; Rabian C; Burgard M; Peytavin G; Rouzioux C; Viard JP
AIDS; 1998 Mar; 12(5):535-7. PubMed ID: 9543456
[No Abstract] [Full Text] [Related]
19. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 viral load and clinical outcome: review of recent studies.
Riddler SA; Mellors JW
AIDS; 1997; 11 Suppl A():S141-8. PubMed ID: 9451978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
